chrisvoncsefalvay/vaers-outcomes huggingface dataset:
LEG NUMBNESS; LEG THROBBING / SORE ARM; CHILLS; TIREDNESS; HEADACHE; FEVER; This spontaneous report received from a patient concerned a 19 year old female. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced leg numbness. On 09-APR-2021, the subject experienced leg throbbing / sore arm. On 09-APR-2021, the subject experienced chills. On 09-APR-2021, the subject experienced tiredness. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the leg numbness, tiredness, headache, chills, fever and leg throbbing / sore arm was not reported. This report was non-serious..
This spontaneous report as received from a nurse refers to a 12 month old male patient. On 25-APR-2014 the patient was vaccinated with (Oka/Merck) VARIVAX injection (lot#and expiration date not provided) (dose not reported). It was reported that the patient received improperly stored (Oka/Merck) VARIVAX exposed to a maximum temperature of -7C for 27 hours. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
On 14 Feb 2021, she received the second dose of the covid vaccine, and has not had to take anything for her blood pressure since; This is a spontaneous report from a contactable physician (patient). An 87-year-old female patient received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9266, Expiry date: not reported, age at vaccination: 87-year-old), via an unspecified route of administration, in Arm Left on 14Feb2021 12:00 as single dose for COVID-19 immunization. Medical history included, Afib (atrial fibrillation), thrombosis and cardiac pacemaker insertion (called an electrocardiologist who told her to discontinue taking amlodipine). Concomitant medication included apixaban (ELIQUIS) at a dosage of 2.5mg twice a day, since an unknown date taken to prevent thrombosis as years ago, she had a few episodes of A-fib, but she had none since. Historical vaccine included first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3247), via an unspecified route, in Arm left on 20Jan2021 at 10:50 for (age at the time of vaccination: 86-year-old) for COVID-19 immunization. Patient previously took lisinopril (Taking 40mg of lisinopril a day for 20 years, in addition to amlodipine) and amlodipine (not taken amlodipine in over a year, because she has not needed it). The facility ran out of the Pfizer covid vaccine, so she got her second dose of the covid vaccine four days later than she was suppose to. On 14Feb2021, she received the second dose of covid vaccine, and had not taken anything for her blood pressure since. She can not remember an exact date, she knows that it was around that time. In the beginning, she did not connect not having to take her blood pressure medication was affected by the covid vaccine. It stuck her whenever she realized she has taken nothing for the past few days. She thought that this was not serious at all. However, she was taking the medication and monitoring her blood pressure. If a patient would not have been monitoring their blood pressure, they could have taken it anyways and passed out. If there was a relationship between this and the covid vaccine, she thinks it is medically significant. She thought the time frame was a coincidence. She did not think of it at first, because of the mechanism of action of ace inhibitors. She got to thinking about it and was wondering about the mechanism of action of the covid vaccine, and called Pfizer. No other vaccines were administered on the same date as Pfizer suspect and no other prior vaccinations within 4 weeks. Patient was not administered to ER and not visit physician office. The outcome of events was unknown.
This case was reported by a consumer and described the occurrence of adverse reaction in a male patient who received FLULAVAL (batch number MJ7A9, expiry date June 2015). On 23rd January 2015, the patient received FLULAVAL. In 2015, an unknown time after receiving FLULAVAL, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to FLULAVAL. Additional details were provided as follows: This case was reported by a pharmacy via a pharmacy claims management company. The patient experienced an adverse reaction (unspecified) after the vaccination with FLULAVAL. The reported batch number (MJ749) for FLULAVAL did not exist and was updated to MJ7A9 as per the sales database.
I've been having heart palpitation; headaches; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PALPITATIONS (non-serious), outcome "unknown", described as "I've been having heart palpitation"; HEADACHE (non-serious), outcome "unknown", described as "headaches".  Additional information- It was reported that patient  been having heart palpitation & headaches since vaccinated (I got the Pfizer shots) thinking of doing a EKG. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
lower back pain; malaise; chills; muscle pain at the site; osteoporosis flared up; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (lower back pain), MALAISE (malaise), OSTEOPOROSIS (osteoporosis flared up), VACCINATION SITE PAIN (muscle pain at the site) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (muscle pain at the site). On 08-Jan-2021, the patient experienced MALAISE (malaise) and CHILLS (chills). On 09-Jan-2021, the patient experienced BACK PAIN (lower back pain). In January 2021, the patient experienced OSTEOPOROSIS (osteoporosis flared up). In January 2021, VACCINATION SITE PAIN (muscle pain at the site) had resolved. At the time of the report, BACK PAIN (lower back pain), MALAISE (malaise) and CHILLS (chills) had not resolved and OSTEOPOROSIS (osteoporosis flared up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  Company comment:Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded The lower back pain and osteoporosis events may be related to the patient's history of osteoporosis.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded The lower back pain and osteoporosis events may be related to the patient's history of osteoporosis.
It started with a sore throat. I had headaches and I got a lot of respiratory symptoms like a cough. I felt super tired and lethargic. I felt okay and I thought I was good to go and I was up doing stuff all over the house. I took a downhill turn because I would do too much. After that, that's when the coughing and respiratory stuff started. They gave me an oral steroid treatment and the z-pack antibiotic. By day 14 of COVID-19, my right hand and wrist started really hurting. At first, they thought it was cellulitis because I've had that before and it was similar. My hand swelled a little bit, and the pain was similar. The last day of my treatment, my left hand immediately started the same pain. This wasn't the same as cellulitis and I went to the ER a couple of times. My doctor ran initial tests and he was suspicious about it being an autoimmune issue. He tested me and noted I was high in some factors for rheumatoid arthritis. I couldn't see the rheumatologist until October 17. I was on steroids several times, went to the ER several times, and was trying to control the pain until I could get into the rheumatologist. All the doctors said that they noticed that if you possibly have an underlying autoimmune condition, COVID-19 can possibly bring that up to the surface, so that's probably what happened. On October 18, I did start treatment for RA. The medication I'm currently talking is sulfasalazine. Hands are still experiencing pain daily. The mobility in my hands has decreased, especially in the morning. Some days are better than others. I also take celecoxib and more supplements.
ACUTE NON ST ELEVATION MI  ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Reports shock like episodes twice, no swelling, but was lethargic, confused, appears to have lost consciousness, Occurred twice, once ~18 hours and again ~22 hours after vaccine administration, lasted 10 and 5 minutes respectively . Similar issue happened with 2nd dose, reported to VAERS
fever; significant arm swelling; feeling ill; dry cough; extreme fatigue; This spontaneous report has been received from a 72 year old female patient. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not provided.      On 03-NOV-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, route, frequency, anatomical location, lot # and expiration date were not provided) 0.5 milliliter for prophylaxis. Other suspect therapies included influenza virus split virion 4v vaccine inactivated (FLUZONE) (strength, indication, dose, route, frequency, anatomical location, lot # and expiration date were not provided).On the same date, the patient experienced fever, significant arm swelling, especially on the vaccination side, dry cough, extreme fatigue and "feeling ill". On 30-NOV-2020, the patient went to visit a clinic where a chest ray and a bloodwork were drawn, however, no result had been received yet. The patient sought for medical attention, but no treatment was given. At the reporting time, the outcome of pyrexia, fatigue, cough, malaise and peripheral swelling was reported as not resolved. The causality assessment was not provided.
Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: Felt little numbness and tingling down the left hand/same side of injection
RIGHT THIGH BECAME RED, SWOLLEN AND PAINFUL  TREATMENT: LESS LIKELY TO BE INFECTION BUT WILL TREAT IN CASE SINCE HE IS TENDER, ESPECIALLY ON THE RIGHT THIGH ZYRTEC DAILY AND IF NEEDED BENADRYL AT BEDTIME FOR ITCHING CEPHALEXIN SUSPENSION RECONSTITUTED, 250MG/5ML, 12 ml, ORALLY, EVERY 12 HRS, 7 DAYS, 168 ml, refills 0
Injection site pain; injection site erythema Information has been received from a registered nurse concerning an 18 year old male with asthma who on 01-DEC-2005 was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine (Lot #651318/1006P). Concomitant therapy given into the other arm included a dose of influenza virus vaccine (unspecified) (no reaction noted). On 01-DEC-2005 (previously report as 04-DEC-2005) the patient was seen in the doctor's office with an injection site reaction described as pain and redness. No diagnostic laboratory studies were performed. The patient was treated with cephalexin (Keflex). Four days later, the patient's symptoms completely resolved. No product quality complaint was involved. Additional information is not expected.
arm pain that really hurt after first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain that really hurt after first dose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer, Benign renal neoplasm (a benign mass on her left kidney), Stevens Johnson syndrome (after getting a facial after being in sun and also receiving radiation for breast cancer.), Radiation therapy and Chemotherapy (radiation and chemotherapy treatments for breast cancer 14 years ago.). Concurrent medical conditions included Immunocompromised (underlying autoimmune conditions and is considered immunocompromised due to a past medical history). Concomitant products included COLECALCIFEROL (VITAMIN D3) for Osteoporosis, FEXOFENADINE HYDROCHLORIDE (ALLEGRA), ALPRAZOLAM, ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS), CLONAZEPAM (KLONOPIN), PITAVASTATIN CALCIUM (LIVALO), ZOLPIDEM TARTRATE (ZOLPIDEM [ZOLPIDEM TARTRATE]), DENOSUMAB (PROLIA), LACTOBACILLUS ACIDOPHILUS (ACIDOPHILUS PROBIOTIC), AIRBORNE, FLUTICASONE PROPIONATE (ALLER FLO), DOXEPIN, CHONDROITIN SULFATE, GLUCOSAMINE (MOVE FREE [CHONDROITIN SULFATE; GLUCOSAMINE]), MULTIVITAMIN [VITAMINS NOS] and ESTROGENS CONJUGATED (PREMARIN) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm pain that really hurt after first dose). On 02-Feb-2021, PAIN IN EXTREMITY (arm pain that really hurt after first dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications provided by the reporter.   Patient experienced arm pain that really hurt after receiving the vaccine; however, patient states she had "nothing" the next day.   Doses were administered in the patient's right upper arm, which is her dominant arm, due to lymphadenopathy in her left arm as a result of radiation and chemotherapy treatments for breast cancer 14 years ago.   This case was linked to MOD-2021-356901, MOD-2021-356902 (Patient Link).
On June 16 had shingles vaccine and 30 min later had a reaction. Symptoms have been constant since then. She has pressure left frontal/temple/side of head or face, behind the left eye, also feels intense dizziness (lightheaded like not inhabiting her body completely, no spinning), nauseous, fatigued. Sensitive to light and sound but had this at baseline as well. Maybe less intense then the beginning. Symptoms come and go like spells. No time of day more prominent. Usually lasts 10-15 min at a time but would return. Sometimes will have numbness left side of nose. Episodes occur daily since injection. No change in vision. She does feel her memory is not as good as it was (retrieval of names is more difficult), feels more foggy since the vaccine. In the first two weeks (after had to take a 1.5 hr nap every day which was much different for her. Initially had numbness/tingling to the left around her mouth but has not felt that since last week. Never had drooling or dribbling out the side of her mouth. No trouble or pain with chewing. No rashes.
AFTER KINRIX ADMINISTRATION TO LEFT DELTOID ON 4/7/09 PATIENT DEVELOPED REDNESS, SWELLING AND PAIN TO UPPER LEFT ARM.
13 year old patient had interruption in dosing schedule pertaining to MMR II / Patient received first dose of MMR II at 1 years old; No additional adverse events reported; This spontaneous report was received from a Medical Assistant and refers to a currently 13-year-old patient (gender not informed).  The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On an unknown date, at the age of 1 year old, the patient was vaccinated with a first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection (dose, route of administration, lot number, and expiration date not reported) administered for prophylaxis.  It was reported that the patient had interruption in dosing schedule pertaining to this vaccine (Inappropriate schedule of product administration). No additional adverse events were reported (No adverse event). No further details were provided.
85 yo M with past medical history significant for diabetes mellitus type II and hypertension, received Pfizer vaccine in April/May.  He presented to the hospital with fever and chills x 2 days but reports no other symptoms.  He was found to be COVID positive and with RLL pneumonia on imaging
Sore arm; Coughing; Sneezing; This spontaneous case was reported by a patient and describes the occurrence of COUGH (Coughing), SNEEZING (Sneezing) and PAIN IN EXTREMITY (Sore arm) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], PARACETAMOL (TYLENOL), ATORVASTATIN CALCIUM (LIPITOR) and METFORMIN for an unknown indication.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jun-2021, the patient experienced COUGH (Coughing) and SNEEZING (Sneezing). On 24-Jun-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, COUGH (Coughing), SNEEZING (Sneezing) and PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment- Alka Seltzer Sinus was reported.
Patient reported on 5/3/2021 that he had experienced headaches following the second dose of Moderna.  Reports that it has happened about three times since the second dose that was given on 4/14/2021.  Reports that later in the day of 4/14/2021 that he experienced a sharp, intense pain to the left backside of his head that resolved 2-3 hours later.  Then reports these same type of headaches about 3 times and reports has a dull headache today(5/3/21).  States tylenol has helped to relieve the headaches when he had them.
101 temp pm 07/11 feels like "ran over by train" small shortness of breath and itch
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. No information on patient's medical history, concurrent conditions or concomitant medications was provided. On an unknown date in 2016, the patient was vaccinated with the improperly stored dose of VARIVAX (Merck) (lot # L034368, expiration date 08-SEP-2017; dose and route were not provided). No adverse effects were reported. The vaccine was exposed to 17.2 Fahrenheit (F) for 2 hours on 12-JAN-2016 and to 8.1 F for 12 hours on an unknown date in 2016. This is one of several reports received form the same reporter. Additional information has been requested.
6cm X 7 1/2cm erythematous and warm to touch area at left shoulder. Given E-Mycin and Hydrocortisone cream and Benadryl. Use ice prn. This event happened 24 hours, later. Treated on 2/1/00 at 12:55.
I felt absolutely terrible, had a sore throat with phlegm, low grade temperature, fatigue. I took a home COVID-19 test that came back positive. I called my General Practitioner who sent me to see her Nurse Practitioner who prescribed Lagevrio (Moinupiravir) and inhaler. I only took the antiviral and that worked like magic, I now only have very little phlegm going down my throat.
This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's friend) reported that a female patient of an unspecified age and ethnicity received PREVNAR 13 via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The consumer stated that pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) had "way too many side effects" and on an unspecified date, the patient who had the vaccine had a huge lump on her arm. The outcome of the event was unknown. No follow-up attempts are possible, information about batch number cannot be obtained. No further information is expected.
Patient report of rash on his upper torso and arms. No itching or shortness of breath noted.
Corneal Ulcer, coronary ulcer; This case was reported by a other health professional via sales rep and described the occurrence of corneal ulcer in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th February 2022, the patient received the 1st dose of Shingrix (intramuscular). On 16th February 2022, 1 days after receiving Shingrix, the patient experienced corneal ulcer (serious criteria GSK medically significant). On an unknown date, the outcome of the corneal ulcer was unknown.   It was unknown if the reporter considered the corneal ulcer to be related to Shingrix.  Additional details were provided as follows: The reporter reported the patient received her Shingrix vaccine in (unknown arm) and the corneal ulcer (coronary ulcer) developed in unknown eye. The reporter reported that the patient received treatment from her eye doctor and then reported it to the GlaxoSmithKline representative's healthcare professional .  No further information was known. The reporter consented to follow up.
Within 10min difficulty swallowing, tongue swelling, shortness of breath. Following resuscitation on-going shortness of breath for >10 days. On high dose steroids and q6h benadryl for 5 days then 7 days of steroid taper with PRN albuterol for shortness of breath.
OBSTRUCTIVE SLEEP APNEA PERIPHERAL NEUROPATHY 2/6/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Lump and pain with rash noted 10 days after Injection. Itchy and hot to touch
I?ve been to 4 different emergency rooms on different days in the past 4 months and they don?t know what the problem is . My primary doctor referred me to an RA who said what I had was weird and he couldn?t help. My pains are so severe that I don?t sleep for days .
This spontaneous report as received from an office's vaccine coordinator via field representative refers to a patient of unknown demographics. On an unknown date in November 2013 the patient was vaccinated with ROTATEQ vial standard second dose orally for prevention of rotavirus. Dose, lot number and expiry date were unknown. On an unknown date in November 2013, the patient developed blood in stool after vaccination. The field representative had made an attempt to report these events within the 24 hour reporting period on Wednesday 27-NOV-2013 however was unable to connect with the after-hours reporting system to leave a message. The outcome of blood in stool is unknown. The field representative mentioned that the events described in this report and the linked case (1312USA001477) occurred with patients who were administered ROTATEQ from the same unspecified lot number and expiry date. This is 1 of 2 reports from the same reporter. Additional information has been requested.
chest pain , Palpitation?  numbness in legs in short period of sitting.  fatigue
Patient had a sharp pain  down her entire arm several hours after the initial injection that lasted for about 8 hours.  She also had facial flushing, but no fever.  Patient also said she was yawning every 30 seconds or so.